The overall prevalence rate of anti-HEV IgG and IgM among IBD patients (12.3% and 6.4%, respectively) in our study was higher compared to similar studies (1.3% and 2.7% for IgG and IgM, respectively) [19]. Here, CD40LG is linked to inflammatory bowel disease.